Ionis Pharmaceuticals Price Target Cut to $80.00/Share From $89.00 by Guggenheim
Ratings actions from Benzinga
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Ratings actions from Benzinga
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.